MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20093590.
- Also identified by DOI 10.2214/AJR.09.3522.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this article is to describe the role of MR, CT, and PET/CT in the detection of ovarian cancer and the evaluation of adnexal lesions. The goal of imaging in ovarian cancer detection is to expeditiously distinguish benign adnexal lesions from those requiring further pathologic evaluation for malignancy. For lesions indeterminate on ultrasound, MRI increases the specificity of imaging evaluation, thus decreasing benign resections. CT is useful in diagnosis and treatment planning of advanced cancer. Although (18)F-FDG-avid ovarian lesions in postmenopausal women are considered suspicious for malignancy, PET/CT is not recommended for primary cancer detection because of high false-positive rates.
Medical subject headings
- Adnexal Diseases
- Magnetic Resonance Imaging
- Ovarian Neoplasms
- Tomography, Emission-Computed
- Tomography, X-Ray Computed